MDSL
PFE icon

M.D. Sass LLC’s Pfizer PFE Stock Holding History

M.D. Sass LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,826
Closed -$1.03M – 45
2019
Q4 		$1.03M Sell
27,826
-4,637
-14% -$165K 0.24% 36
2019
Q3 		$1.11M Sell
32,463
-7,800
-19% -$284K 0.26% 42
2019
Q2 		$1.66M Hold
40,263
– – 0.38% 40
2019
Q1 		$1.62M Sell
40,263
-5,164
-11% -$207K 0.26% 41
2018
Q4 		$1.88M Hold
45,427
– – 0.32% 37
2018
Q3 		$1.9M Sell
45,427
-21,080
-32% -$812K 0.25% 37
2018
Q2 		$2.29M Sell
66,507
-9,908
-13% -$339K 0.29% 35
2018
Q1 		$2.57M Buy
76,415
+11,910
+18% +$409K 0.3% 37
2017
Q4 		$2.22M Sell
64,505
-39,630
-38% -$1.35M 0.2% 46
2017
Q3 		$3.53M Hold
104,135
– – 0.3% 42
2017
Q2 		$3.32M Sell
104,135
-4,322
-4% -$136K 0.22% 40
2017
Q1 		$3.52M Buy
108,457
+738
+0.7% +$23.3K 0.18% 40
2016
Q4 		$3.32M Buy
107,719
+3,795
+4% +$116K 0.19% 42
2016
Q3 		$3.34M Sell
103,924
-98,022
-49% -$3.28M 0.19% 35
2016
Q2 		$6.75M Sell
201,946
-2,214
-1% -$70.7K 0.33% 31
2016
Q1 		$5.74M Buy
204,160
+15,729
+8% +$449K 0.31% 32
2015
Q4 		$5.77M Buy
188,431
+43,967
+30% +$1.38M 0.32% 32
2015
Q3 		$4.3M Buy
144,464
+32,991
+30% +$1.06M 0.24% 47
2015
Q2 		$3.55M Buy
111,473
+2,068
+2% +$67.4K 0.18% 55
2015
Q1 		$3.61M Buy
109,405
+38,049
+53% +$1.21M 0.18% 51
2014
Q4 		$2.11M Hold
71,356
– – 0.13% 52
2014
Q3 		$2M Buy
71,356
+53,513
+300% +$1.5M 0.12% 54
2014
Q2 		$502K Buy
17,843
+9,502
+114% +$271K 0.03% 52
2014
Q1 		$254K Sell
8,341
-302
-3% -$9K 0.02% 52
2013
Q4 		$251K Buy
+8,643
New +$252K 0.02% 45
2013
Q3 		– Sell
-53,438
Closed -$1.42M – 45
2013
Q2 		$1.42M Buy
+53,438
New +$1.48M 0.12% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

M.D. Sass LLC's PFE Position: Q1 2020 in Review

M.D. Sass LLC sold out of Pfizer (PFE) in Q1 2020, closing a stake of 27,826 shares — an estimated $1.03M sold.

M.D. Sass LLC first reported a position in PFE in Q2 2013 and held it in 26 quarters. The position peaked at $6.75M in Q2 2016. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • M.D. Sass LLC reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • M.D. Sass LLC sold 27,826 Pfizer shares in Q1 2020, an estimated $1.03M.
  • M.D. Sass LLC first reported a position in Pfizer in Q2 2013 and held it in 26 quarters.
  • M.D. Sass LLC's Pfizer position peaked at $6.75M in Q2 2016.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on M.D. Sass LLC's 13F filing for Q1 2020, filed 6 May 2020.